Belite Bio Inc (BLTE)
48.22
-0.33
(-0.68%)
USD |
NASDAQ |
Sep 20, 16:00
48.22
0.00 (0.00%)
After-Hours: 20:00
Belite Bio Total Assets (Quarterly): 118.43M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 118.43M |
| March 31, 2024 | 101.15M |
| December 31, 2023 | 94.64M |
| September 30, 2023 | 57.60M |
| June 30, 2023 | 60.70M |
| Date | Value |
|---|---|
| March 31, 2023 | 39.82M |
| December 31, 2022 | 44.27M |
| June 30, 2022 | 51.06M |
| December 31, 2021 | 18.35M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
18.35M
Minimum
Dec 2021
118.43M
Maximum
Jun 2024
65.11M
Average
57.60M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
| Theriva Biologics Inc | 42.39M |
| Oragenics Inc | 2.710M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.837M |
| Shareholders Equity (Quarterly) | 114.59M |